Strategic Management
Table of Contents
Introduction…………………………………..……………………………………..………….. 3
Company History and Description ………………...………………………………………… 3
Industry Description …………………………………………………………..………………. 4
Global Expansion ………………………………………..………………………………….… 4
Current Situation …………………………………………………………………………….... 5
Current Performance ………………..…………………………………….………………….. 5
Market Share ………………………………………………………….……………………..... 6
Strategic Posture..……………..………………………………………………………………. 7
Corporate Governance ………………………………...………………………………….….. 7
Corporate Governance Facts ………………………………………………………….…... 10
Board of Directors …………………………………………………………………………… 11
Securities Ownership ……………………………………………………………………….. 14
External Environment ………………………………………………………………………...16
Opportunities and Threats (OT) ...…………………………………………………………...16
Natural Environment ………………………………………………………………………….16
Societal Environment …………………………………………………………………………16
Task Environment …………………………………………………………………………….17
EFAS Matrix Analysis ……………………………………………………………………….. 18
Introduction
Global pharmaceuticals grew by 3.6% in 2010 to reach over $733 billion with projections reaching $981 billion by the year 2015 (Pharmaceuticals Industry Profile: Global, 2011). Pfizer, the world leader in the global pharmaceuticals market, controls an impressive 9.4% of the global market share (Pharmaceuticals Industry Profile: Global, 2011). Sometimes described as Frankenstein’s Monster, Pfizer has been aggressively swallowing up smaller companies since the early 1990’s to become the present day drug giant. Pfizer along with other companies will be facing a fork in the road in the near future as they exit their blockbuster growth with the expiration of many of the company’s most successful drug patents. In this paper we will conduct several analyses to identify strategies that would be viable options for the company. Pfizer, which has been a company that has dominated with its inorganic growth in the past (Appendix N), will now have to decide
Introduction…………………………………..……………………………………..………….. 3
Company History and Description ………………...………………………………………… 3
Industry Description …………………………………………………………..………………. 4
Global Expansion ………………………………………..………………………………….… 4
Current Situation …………………………………………………………………………….... 5
Current Performance ………………..…………………………………….………………….. 5
Market Share ………………………………………………………….……………………..... 6
Strategic Posture..……………..………………………………………………………………. 7
Corporate Governance ………………………………...………………………………….….. 7
Corporate Governance Facts ………………………………………………………….…... 10
Board of Directors …………………………………………………………………………… 11
Securities Ownership ……………………………………………………………………….. 14
External Environment ………………………………………………………………………...16
Opportunities and Threats (OT) ...…………………………………………………………...16
Natural Environment ………………………………………………………………………….16
Societal Environment …………………………………………………………………………16
Task Environment …………………………………………………………………………….17
EFAS Matrix Analysis ……………………………………………………………………….. 18
Introduction
Global pharmaceuticals grew by 3.6% in 2010 to reach over $733 billion with projections reaching $981 billion by the year 2015 (Pharmaceuticals Industry Profile: Global, 2011). Pfizer, the world leader in the global pharmaceuticals market, controls an impressive 9.4% of the global market share (Pharmaceuticals Industry Profile: Global, 2011). Sometimes described as Frankenstein’s Monster, Pfizer has been aggressively swallowing up smaller companies since the early 1990’s to become the present day drug giant. Pfizer along with other companies will be facing a fork in the road in the near future as they exit their blockbuster growth with the expiration of many of the company’s most successful drug patents. In this paper we will conduct several analyses to identify strategies that would be viable options for the company. Pfizer, which has been a company that has dominated with its inorganic growth in the past (Appendix N), will now have to decide
References: http://www.pfizer.com/files/corporate_citizenship/cr_report/manufact_supply.pdf http://www.pfizer.com/investors/financial_reports/annual_reports/2012/downloads/pfizer_12ar_ensuring_global_supply.pdf http://www.theofficialboard.com/org-chart/pfizer http://www.pfizer.com/files/investors/corporate/blue_book_english.pdf